ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2023

Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis.

Hareer Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.